Hypertension Journal Articles

2020

• Meador M, Lewis JH, Bay RC, Wall HK, Jackson C. Who are the undiagnosed? Disparities in hypertension diagnoses in vulnerable populationsexternal icon. Fam Community Health. 2020;43(1):35–45.
• Ritchey MD, Hannan J, Wall HK, George MG, Sperling LS. Notes from the Field: Characteristics of Million Hearts Hypertension Control Champions, 2012–2019. 2020;69(7):196–197.

2019

• Campbell NRC, He FJ, Tan M, Cappuccio FP, Neal B, Woodward M, et al. The International Consortium for Quality Research on Dietary Sodium/Salt (TRUE) position statement on the use of 24-hour, spot, and short duration (<24 hours) timed urine collections to assess dietary sodium intakeexternal icon. J Clin Hypertens (Greenwich). 2019;21(6):700–709.
• Chang TE, Ritchey MD, Park S, Chang A, Odom EC, Durthaler J, et al. National rates of nonadherence to antihypertensive medications among insured adults with hypertension, 2015external icon. Hypertension. 2019;74(6):1324–1332.
• Fang J, Zhang Z, Ayala C, Thompson-Paul AM, Loustalot F. Cardiovascular health among non-Hispanic Asian Americans: NHANES, 2011–2016external icon. J Am Heart Assoc. 2019;8(13):e011324.
• Ferguson JM, Costello S, Neophytou AM, Balmes JR, Bradshaw PT, Cullen MR, et al. Night and rotational work exposure within the last 12 months and risk of incident hypertensionexternal icon. Scand J Work Environ Health. 2019;45(3):256–266.
• He FJ, Ma Y, Campbell NRC, MacGregor GA, Cogswell ME, Cook NR. Formulas to estimate dietary sodium intake from spot urine alter sodium-mortality relationshipexternal icon. 2019;74(3):572–580.
• Jackson SL, Ayala C, Tong X, Wall HK. Clinical implementation of self-measured blood pressure monitoring, 2015–2016external icon. Am J Prev Med. 2019;56(1):e13–e21.
• Overwyk KJ, Dehmer SP, Roy K, Maciosek MV, Hong Y, Baker-Goering MM, et al. Modeling the health and budgetary impacts of a team-based hypertension care intervention that includes pharmacistsexternal icon. Med Care. 2019;57(11):882–889.

2018

• Ahuja R, Ayala C, Tong X, Wall HK, Fang J. Public awareness of health-related risks from uncontrolled hypertension. Prev Chronic Dis. 2018;15:E40.
• Chang TE, Ritchey MD, Ayala C, Durthaler JM, Loustalot F. Use of strategies to improve antihypertensive medication adherence within United States outpatient health care practices, DocStyles 2015–2016external icon. J Clin Hypertens (Greenwich). 2018;20(2):225–232.
• Ciemins EL, Ritchey MD, Joshi VV, Loustalot F, Hannan J, Cuddeback JK. Application of a tool to identify undiagnosed hypertension — United States, 2016. 2018;67(29):798–802.
• Fang J, Gillespie C, Ayala C, Loustalot F. Prevalence of self-reported hypertension and antihypertensive medication use among adults aged ≥18 years — United States, 2011–2015. 2018;67(7):219–224.
• Heisey-Grove DM, Wall HK, Wright JS. Electronic clinical quality measure reporting challenges: findings from the Medicare EHR Incentive Program’s Controlling High Blood Pressure Measureexternal icon. J Am Med Inform Assoc. 2018;25(2):127–134.
• Jackson SL, Zhang Z, Wiltz JL, Loustalot F, Ritchey MD, Goodman AB, et al. Hypertension among youths — United States, 2001–2016. 2018;67(27):758–762.
• Park S, Gillespie C, Baumgardner J, Yang Q, Valderrama AL, Fang J, et al. Modeled state-level estimates of hypertension prevalence and undiagnosed hypertension among US adults during 2013–2015external icon. J Clin Hypertens (Greenwich). 2018;20(10):1395–1410.
• Patel P, Speight C, Maida A, Loustalot F, Giles D, Phiri S, et al. Integrating HIV and hypertension management in low-resource settings: lessons from Malawiexternal icon. PLoS Med. 2018;15(3):e1002523.
• Reboussin DM, Allen NB, Griswold ME, Guallar E, Hong Y, Lackland DT, et al. Systematic review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelinesexternal icon [published correction appears in Hypertension. 2018 Jun;71(6):e145]. 2018;71(6):e116–e135.
• Ritchey MD, Gillespie MS, Wozniak G, Shay CM, Thompson‐Paul AM, Loustalot F, et al. Potential need for expanded pharmacologic treatment and lifestyle modification services under the 2017 ACC/AHA Hypertension Guidelineexternal icon. J Clin Hypertens. 2018 September; 20(10):1377–1391.
• Ritchey MD, Wall HK, Owens PL, Wright JS. Vital Signs: state-level variation in nonfatal and fatal cardiovascular events targeted for prevention by Million Hearts 2022. 2018;67:974–982.
• Va P, Luncheon C, Thompson-Paul AM, Fang J, Merritt R, Cogswell ME. Self-reported receipt of advice and action taken to reduce dietary sodium among adults with and without hypertension — nine states and Puerto Rico, 2015. 2018;67(7):225–229.
• Wright JS, Wall HK, Ritchey MD. Million Hearts 2022: small steps are needed for cardiovascular disease preventionexternal icon. 2018;320(18):1857–1858.
• Young A, Ritchey MD, George MG, Hannan J, Wright J. Characteristics of health care practices and systems that excel in hypertension control. Prev Chronic Dis. 2018;15(6):E73.
• Zheutlin AR, Hu H, Weisskopf MG, Sparrow D, Vokonas PS, Park SK. Low-level cumulative lead and resistant hypertension: a prospective study of men participating in the Veterans Affairs Normative Aging Studyexternal icon. J Am Heart Assoc. 2018;7(21):e010014. doi:10.1161/JAHA.118.010014

2017

• Ayala C, Tong X, Neeley E, Lane R, Robb K, Loustalot F. Home blood pressure monitoring among adults—American Heart Association Cardiovascular Health Consumer Survey, 2012external icon. J Clin Hypertens (Greenwich). 2017;19(6):584–591.
• Fang J, Wang G, Ayala C, Lucido SJ, Loustalot F. Healthcare access among young adults: impact of the Affordable Care Act on young adults with hypertensionexternal icon. Am J Prev Med. 2017;53(6S2):S213–S219.
• Frieden TR, Wright JS, Conway PH. Is rapid health improvement possible? Lessons from the Million Hearts initiativeexternal icon. 2017;135(18):1677–1680.
• Hales CM, Carroll MD, Simon PA, Kuo T, Ogden CL. Hypertension prevalence, awareness, treatment, and control among adults aged ≥18 years — Los Angeles County, 1999–2006 and 2007–2014. 2017;66(32):846–849.
• Ritchey MD, Loustalot F, Wall HK, Steiner CA, Gillespie C, George MG, et al. Million Hearts: description of the national surveillance and modeling methodology used to monitor the number of cardiovascular events prevented during 2012–2016external icon. J Am Heart Assoc. 2017;6(5):e006021.
• Stefaniak AB, LeBouf RF, Duling MG, Yi J, Abukabda AB, McBride CR, et al. Inhalation exposure to three-dimensional printer emissions stimulates acute hypertension and microvascular dysfunctionexternal icon. Toxicol Appl Pharmacol. 2017;335:1–5.
• Yang Q, Chang A, Ritchey MD, Loustalot F. Antihypertensive medication adherence and risk of cardiovascular disease among older adults: a population-based cohort studyexternal icon. J Am Heart Assoc. 2017;6(6):e006056.
• Zhang D, Wang G, Joo H. A systematic review of economic evidence on community hypertension interventionsexternal icon. Am J Prev Med. 2017;53(6S2):S121–S130.
• Zhang D, Wang G, Zhang P, Fang J, Ayala C. Medical expenditures associated with hypertension in the U.S., 2000–2013external icon. Am J Prev Med. 2017;53(6S2):S164–S171.